Marseille, February 8th, 2008- Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological disorders, announces today that The Michael J. Fox Foundation (MJFF) has awarded the company a Therapeutics Development Initiative grant to pursue the evaluation of compounds preventing mitochondrial dysfunction to treat Parkinson’s disease (PD).
